Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Diversity of Antigen Receptors

Diversity of Antigen Receptors

Antigen receptors are essential components of the immune system crucial in defending the body against foreign invaders. These receptors are present on the surface of B and T cells, enabling them to recognize antigens and mount an appropriate immune response.
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...

Mismatch Repair

Mismatch Repair

Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...

Mismatch Repair

Mismatch Repair

Hybridoma Technology

Hybridoma Technology

Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...

Humoral Immune Responses

Humoral Immune Responses

B Cell Activation and Differentiation

B Cell Activation and Differentiation

The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Hunting for an Antigen: Humoral Immunity in Alzheimer's Disease.

Cells·2026

Same author

Editorial: Gene regulation in lymphocyte development and response.

Frontiers in immunology·2026

Same author

Lifestyle intervention is associated with attenuation of ER stress/inflammation and enhancement of naive immune cell identity in older adults with metabolic disease.

bioRxiv : the preprint server for biology·2026

Same author

Functional interaction surfaces of the bacterial transcription terminator Rho are required for the interactions with the elongation factor NusG.

The Biochemical journal·2026

Same author

B cell receptor stimulation inhibits class switch recombination through elevated DNA repair.

DNA repair·2026

Same author

Chromatin folding principles underlying the generation of antibody diversity.

Molecular cell·2026

Search research articles

Related Experiment Video

Updated: Jul 1, 2026

Assessing Somatic Hypermutation in Ramos B Cells after Overexpression or Knockdown of Specific Genes

Assessing Somatic Hypermutation in Ramos B Cells after Overexpression or Knockdown of Specific Genes

Published on: November 1, 2011

Regulating antibody diversity: taming a mutagen.

Patricia J Gearhart¹, Ranjan Sen

¹Laboratory of Molecular Gerontology, National Institute on Aging, National Institutes of Health, 251 Bayview Boulevard, Baltimore, MD 21224, USA. gearhartp@grc.nia.nih.gov

|September 9, 2008

Summary

Researchers discovered a novel protein interacting with activation-induced deaminase, influencing key processes in immunoglobulin gene diversification. This finding sheds light on the mechanisms of somatic hypermutation and class switching.

More Related Videos

Generation of Discriminative Human Monoclonal Antibodies from Rare Antigen-specific B Cells Circulating in Blood

Generation of Discriminative Human Monoclonal Antibodies from Rare Antigen-specific B Cells Circulating in Blood

Published on: February 6, 2018

Generation of Human Chimeric Antigen Receptor Regulatory T Cells

Generation of Human Chimeric Antigen Receptor Regulatory T Cells

Published on: January 3, 2025

Related Experiment Videos

Last Updated: Jul 1, 2026

Assessing Somatic Hypermutation in Ramos B Cells after Overexpression or Knockdown of Specific Genes

Assessing Somatic Hypermutation in Ramos B Cells after Overexpression or Knockdown of Specific Genes

Published on: November 1, 2011

Generation of Discriminative Human Monoclonal Antibodies from Rare Antigen-specific B Cells Circulating in Blood

Generation of Discriminative Human Monoclonal Antibodies from Rare Antigen-specific B Cells Circulating in Blood

Published on: February 6, 2018

Generation of Human Chimeric Antigen Receptor Regulatory T Cells

Generation of Human Chimeric Antigen Receptor Regulatory T Cells

Published on: January 3, 2025

Area of Science:

Immunology
Molecular Biology
Genetics

Background:

Immunoglobulin genes undergo dynamic alterations, including somatic hypermutation, class switching, and gene conversion, crucial for adaptive immunity.
Activation-induced deaminase (AID) is a key enzyme initiating these diversification processes.

Discussion:

Conticello et al. identified a novel protein that physically interacts with AID.
This interaction may modulate AID's enzymatic activity or its recruitment to target immunoglobulin loci.
The proposed mechanism involves the spliceosome transcription complex, suggesting a link between RNA processing and DNA diversification.

Key Insights:

A newly identified protein directly interacts with activation-induced deaminase (AID).
This interaction impacts critical immunoglobulin gene diversification events: somatic hypermutation, class switching, and gene conversion.
The spliceosome transcription complex is implicated as a potential mediator of this interaction.

Outlook:

Further studies are needed to elucidate the precise molecular mechanisms by which this protein affects AID function.
Investigating this interaction could reveal new therapeutic targets for autoimmune diseases and B-cell malignancies.
Understanding the role of the spliceosome in DNA diversification may offer insights into genome stability.